By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > CNS stimulants > Modafinil > Modafinil Dosage
CNS stimulants
https://themeditary.com/dosage-information/modafinil-dosage-6112.html

Modafinil Dosage

Drug Detail:Modafinil (Modafinil [ moe-daf-i-nil ])

Drug Class: CNS stimulants

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Narcolepsy

200 mg orally once a day in the morning

Comments:

  • In obstructive sleep apnea (OSA), this drug is not a treatment for the underlying obstruction.
  • If continuous positive airway pressure (CPAP) is the treatment of choice for excessive sleepiness, a maximal effort to treat with CPAP for an adequate period of time should be made prior to and during treatment with this drug.

Use: Treatment to improve wakefulness in patients with excessive sleepiness associated with narcolepsy and OSA.

Usual Adult Dose for Obstructive Sleep Apnea/Hypopnea Syndrome

200 mg orally once a day in the morning

Comments:

  • In obstructive sleep apnea (OSA), this drug is not a treatment for the underlying obstruction.
  • If continuous positive airway pressure (CPAP) is the treatment of choice for excessive sleepiness, a maximal effort to treat with CPAP for an adequate period of time should be made prior to and during treatment with this drug.

Use: Treatment to improve wakefulness in patients with excessive sleepiness associated with narcolepsy and OSA.

Usual Adult Dose for Shift Work Sleep Disorder

200 mg orally once a day, approximately 1 hour prior to the start of the work shift

Use: Treatment to improve wakefulness in patients with excessive sleepiness associated with shift work disorder.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

  • Mild to moderate hepatic impairment: There are no dosage adjustments provided in the manufacturer product information.
  • Severe hepatic impairment: Dose should be reduced by half.

Precautions

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

US Controlled Substance: Schedule IV

Dialysis

Data not available

Other Comments

Administration Advice:

  • This drug can be taken with or without food.
  • Drug tablets should be swallowed whole.

Storage Requirements:
  • This drug should be stored at 20 to 25 degrees Celsius (68 to 77 Fahrenheit).

General:
  • This drug opposes the impairment of cognitive (in particular, memory), psychomotor, and neurosensory performance induced by sleep deprivation in the absence of any appetite or behavior modifications.
  • This drug is a 1:1 racemic compound (90% R-isomer and 10% S-isomer at steady state), whose enantiomers have different pharmacokinetics and do not interconvert.
  • Although this drug has wake-promoting actions akin to sympathomimetic agents (e.g., amphetamine and methylphenidate), it is dissimilar to amphetamine in that its effects are not antagonized by haloperidol and the locomotor activity it induces are not blocked by alpha-methyl-p-tyrosine.
  • Modafinil-induced wakefulness can be attenuated by prazosin; however, modafinil is inactive in other assay systems known to be responsive to alpha-adrenergic agonists (e.g., rat vas deferens preparation).
  • There is no specific antidote for overdosage; induced emesis or gastric lavage should be considered and surveillance of psychomotor status and cardiovascular monitoring is recommended.

Monitoring:
  • Patient monitoring and clinical assessment of treatment need should be performed on a periodic basis as the long-term efficacy (more than 9 weeks) of this drug has not been evaluated.
  • Cardiovascular: Heart rate, blood pressure, general cardiovascular status
  • General: Degree of sleepiness/drowsiness; signs of misuse or abuse
  • Immunologic: Signs and symptoms of angioedema/anaphylaxis
  • Psychiatric: Development of de novo or exacerbation of pre-existing psychiatric disorders (every dose adjustment and regularly during treatment)

Patient Advice:
  • Women who use hormonal birth control methods may have a higher chance of getting pregnant while taking this drug and for 1 month after stopping treatment. Talk to your healthcare provider about alternative birth control options if you use a hormonal birth control method such as birth control pills, shots, implants, patches, vaginal rings, and intrauterine devices (IUDs).
  • Avoid driving and other potentially dangerous activities such as operating machinery during treatment until you know how this drug affects you.
  • Avoid drinking alcohol while taking this drug.
  • This drug may help with sleepiness, but it is not a replacement for getting enough sleep; maintain good sleep hygiene including reviewing your caffeine intake with your healthcare provider.

Frequently asked questions

  • Modafinil vs Adderall: What's the difference?
  • Modafinil: Smart Drug For Decision Fatigue Or Workaholic Crutch?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by